| Literature DB >> 28848589 |
Vibha Pandey1, Waquar Akhter Ansari2, Pratibha Misra3, Neelam Atri2.
Abstract
Withania somnifera, commonly known as Ashwagandha an important medicinal plant largely used in Ayurvedic and indigenous medicine for over 3,000 years. Being a medicinal plant, dried powder, crude extract as well as purified metabolies of the plant has shown promising therapeutic properties. Withanolides are the principal metabolites, responsible for the medicinal properties of the plant. Availability and amount of particular withanolides differ with tissue type and chemotype and its importance leads to identification characterization of several genes/ enzymes related to withanolide biosynthetic pathway. The modulation in withanolides can be achieved by controlling the environmental conditions like, different tissue culture techniques, altered media compositions, use of elicitors, etc. Among all the in vitro techniques, hairy root culture proved its importance at industrial scale, which also gets benefits due to more accumulation (amount and number) of withanolides in roots tissues of W. somnifera. Use of media compostion and elicitors further enhances the amount of withanolides in hairy roots. Another important modern day technique used for accumulation of desired secondary metabolites is modulating the gene expression by altering environmental conditions (use of different media composition, elicitors, etc.) or through genetic enginnering. Knowing the significance of the gene and the key enzymatic step of the pathway, modulation in withanolide contents can be achieved upto required amount in therapeutic industry. To accomplish maximum productivity through genetic enginnering different means of Withania transformation methods have been developed to obtain maximum transformation efficiency. These standardized transformation procedues have been used to overexpress/silence desired gene in W. somnifera to understand the outcome and succeed with enhanced metabolic production for the ultimate benefit of human race.Entities:
Keywords: Ashwagandha; Withania somnifera; differentiation; metabolites; tissue culture; transformation; withanolides
Year: 2017 PMID: 28848589 PMCID: PMC5552756 DOI: 10.3389/fpls.2017.01390
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
Figure 1(A) Some important therapeutic uses of Withania somnifera with few proposed mode of actions (Dar et al., 2015); (B) Possible metabolic pathway for withanolides and glycowithanolides (withanosides) production (Senthil et al., 2010; Dhar et al., 2013; Sabir et al., 2013; Singh et al., 2015b) [GA-3P, glyceraldehyde-3-phosphate; MEP, 2-methyl- D-erythritol 4-phosphate; DMAPP, dimethylalyl pyrophosphate; IPP, isopentenyl pyrophosphate; IPPI, isopentenyl diphosphate isomerise; HMG-CoA, 3-hydroxy-3-methylglutaryl-coenzyme A; DXP, 1-deoxy-D-xylulose 5-phosphate; MVAPK, mevalonate phosphate kinase; MVAPP, diphosphomevalonate decarboxylase; CDP-ME, 4-diphospho-cytidyl-2-methyl-D-erythritol; CMS, 4-(cytidine-5-diphospho)-2-C-tmethyl-Derythritol synthase; CMK, 4-(cytidine-5-diphospho)-2-C-methyl-D-erythritol kinase, CDP-MEP, 2-C-methyl- D-erythritol-2-phosphate; MCS, 2-C-methyl-D-erythritol-2,4-cyclodiphosphate synthase; HDS, Hydroxy methyl butenyl 4- diphosphate synthase; HMBPP, Hydroxy methyl butenyl 4-diphosphate; HDR, Hydroxy methyl butenyl 4-diphosphate reductase].
Different conditions/situation in order to accumulate therapeutically important metabolites of W. somnifera.
| Standardization/ Identification of metabolic-analytical technique/ metabolite | Root; stem; leaf | HPLC for determination of withanolides | WS-1; WS-5 | Ganzera et al., | ||
| Whole plant | cholinesterase inhibiting withanolides | 2-new; 4- known withanolides | Choudhary et al., | |||
| Leaves | Sulfated and oxygenated withanolides | 4-new; 6-known withanolides | Misra et al., | |||
| Dried roots/ leaves | HPLC and AFLP findings to relate different (15) accessions | WS-1; WS-2; WS-3; WS-7; WS-9; WSs; PG | Dhar et al., | |||
| Roots | Rare dimeric withanolide (ashwagandhanolide) | WS-1; WS-3; WS-7; WS-8; WS-14 | Subbaraju et al., | |||
| Two new withanolides (TLC; NMR) | 2-new and 7-known withanolides | Misra et al., | ||||
| Leaves, roots | More reliable HPLC to determine broad range of withanolides | 9- withanolides | Chaurasiya et al., | |||
| Various genotypes | HPTLC for determination of withanolides | WS-1; WS-3; WS-10 | Srivastava et al., | |||
| Leaves, roots | NMR and HPLC and GC–MS for metabolic fingerprinting | 48 to 62 primary/ secondary metabolite | Chatterjee et al., | |||
| Whole plant/ plant parts | Distribution in various organs | WS-3 | Praveen et al., | |||
| Roots, fruits, leaves | Phenolic acids | 5-phenolics; 3-flavonoids; few unknown | Alam et al., | |||
| Leaves, roots | HR-MAS-NMR to establish metabolic mapping (4 chemotypes) | 41 metabolites | Bharti et al., | |||
| Metabolic/ phytochemical profiling | Leaves, stems, roots | Metabolomic characterization (NMR) from different (6) regions | Primary and secondary metabolites | Namdeo et al., | ||
| Roots | Different species | 21 bioactive compounds | Kumar et al., | |||
| Fruits | Developmental stages of fruit (NMR; COSYDQF; TOCSY; HSQC) | 17 metabolites | Sidhu et al., | |||
| Fruits (LC-HRMS and LC-MS/MS) | 62 metabolites | Bolleddula et al., | ||||
| Chemotype (4) variations (GC–MS and NMR) | 82 metabolites | Bhatia et al., | ||||
| Leaves, roots | Clustering of accessions (25) based on phenotypic and chemotypic analysis | WS-1; WS-2; WS-3 | Kumar et al., | |||
| Relation between transcript and metabolic profile in two morpho-chemovariant accessions | WS-1; WS-2; WS-3 | Dhar et al., | ||||
| Different plant parts | Growth dependent variation in few metabolites (2 cultivars) | WS-1; WS-2; WS-3; squalene | Dhar et al., | |||
| Media/soil/elicitortreatment/variation | Leaves | Nitsch and Nitsch-(NN) media + BAP + IBA | WS-1 | Furmanowa et al., | ||
| Parts of seedlings | MS/ B5 basal media + (different combinations of plant hormones) | WS-1; WS-2; WS-3; WS-4; WS-6 | Sharada et al., | |||
| Leaves, stem, roots | MS + BAP, IAA | WS-1; WS-3; WS-10 | Dewir et al., | |||
| Leaves, roots, seedling | Sandy loam soil; MS | WS-1 | Johny et al., | |||
| Multiple shoots, teratoma | MS + BAP + Kinetin | WS-1; WS-3 | Sangwan et al., | |||
| Multiple shoots | MS + BAP+/ IAA+/ IBA+/ NAA+/ 2,4-D | Glycowithanolides; withanolides | Ahuja et al., | |||
| Adventitious roots | MS + IBA + IAA | WS-3 | Wasnik et al., | |||
| MS + 2,4-D/ IAA/ IBA/ NAA; B5 NN; N6 | WS-3 | Praveen and Murthy, | ||||
| Adventitious roots from semi-friable callus of leaves | MS + 2,4-D + kinetin, MS + IBA + IAA | WS-1; WS-2; WS-3; WS-4; WS-10; WS-12; WS-13 | Sivanandhan et al., | |||
| MS + 2,4-D + kinetin, MS + IBA + NAA, Elicitors | WS-1; WS-3; WS-4; WS-12; WS-13 | Sivanandhan et al., | ||||
| Plantlet | Hoagland + MeJA; SA | WS-1; WS-3 | Rana et al., | |||
| Callus culture | MS + 2,4 D + kinetin | WS-1; WS-3 | Chakraborty et al., | |||
| Adventitious root culture | MS + sucrose + IBA; different concentrations/ types of sugars; different pH | WS-3 | Murthy and Praveen, | |||
| Cell suspension culture | MS + 40% | WS-1; WS-2; WS-3; WS-4 | Sivanandhan et al., | |||
| Multiple shoot cultures | MS + BAP + spermidine | WS-1; WS-2; WS-3; WS-4 | Sivanandhan et al., | |||
| Cell suspension culture | MS + kinetin + L-glutamine + sucrose + CaCl2/ NH4Cl/ chitosan/ cholesterol/ MA/ squalene | WS-1; WS-2; WS-3; WS-4; WS-11; WS-12; WS-13 | Sivanandhan et al., | |||
| Shoot suspension culture | MS + | WS-1; WS-2; WS-3; WS-4 | Sivanandhan et al., | |||
| Flowers, fruits | MS + BAP + IAA, sucrose, L-glutamine, adenine sulfate, nitrates of | WS-1; WS-2; WS-3; WS-4 | Sivanandhan et al., | |||
| Whole plant/ plant parts | Different vermicomposts | WS-1; WS-5 | Raja and Veerakumari, | |||
| Leaves, roots | Organic composion of soil (bioaugmented organic + gypsum) | WS-1; WS-2; WS-3 | Gupta et al., | |||
| SA; MeJA; MI (4 chemotypes) | WS-3 | Gupta et al., | ||||
| MeJA; GA3; YE | WS-1; WS-2; WS-3 | Dhar et al., | ||||
| Plantlet | MeJA; SA; GA3 | WS-1; WS-2; WS-3 | Rana et al., | |||
| MeJA; SA; 2,4-D; YE | WS-1; WS-3 | Razdan et al., | ||||
| Strain-plasmid ± gene; tissue used for infection of | Hairy roots | LBA 9402 -pRi 1855; stem, leaves | WS-5 | Ray et al., | ||
| MTCC 2364, MTCC532; stem, hypocotyle, leaves | Not mentioned | Pawar and Maheshwari, | ||||
| LBA 9402; A4-pRiA4; leaves | WS-1; WS-5 | Bandyopadhyay et al., | ||||
| R1601- pRiA4b; different parts of seedling | WS-3 | Murthy et al., | ||||
| LBA9402/ A4 ± synthetic crypt gene; leaves | WS-1 | Chaudhuri et al., | ||||
| 15834; leaves | WS-1; WS-3 | Doma et al., | ||||
| ATCC 15834, R1000, K599; leaves, petiole, internodes | WS-1 | Saravanakumar et al., | ||||
| R1601; cotyledonary leaves | WS-3 | Praveen and Murthy, | ||||
| R1000; leaves | WS-1; WS-2; WS-3 | Sivanandhan et al., | ||||
| A4 ± SGT; leaves | WS-3 | Pandey et al., | ||||
| LBA9402 ±β-cryptogein gene; leaves | WS-1; WS-3 | Sil et al., | ||||
| leaves | WS-1; WS-2; WS-3; WS-4 | Sivanandhan et al., | ||||
| R1000, MTCC 2364, MTCC 532 | WS-1; WS-3 | Thilip et al., | ||||
| Teratoma | Nopaline:C58; octopine:Ach5, disarmed:LBA 4404; leaves | WS-1; WS-5 | Ray and Jha, | |||
| Plantlet | GV3102 - pIG121Hm ±CAS gene/ pGSA1131 ±RNAi; leaves | Total withanolide | Mishra et al., | |||
| Leaves | GV3102- pBI121 ± | WS-3 | Grover et al., | |||
| WS-1; WS-2; WS-3; WS-4 | Patel et al., | |||||
| LBA4404/GV3102 - pFGC1008/pBI121/TRV2/ ±SGT gene/s; leaves | WS-1; WS-2; WS-3; WS-13 | Saema et al., | ||||
| LBA4404-pCAMBIA; leaves | WS-1; WS-2; WS-3; WS-4 | Sivanandhan et al., |
HPLC, high performance liquid chromatography; HPTLC, High performance thin layer chromatography; TLC, Thin layer chromatography; LC-MS, Liquid chromatography-mass spectrometry; NMR, Nuclear magnetic resonance; GC-MS, Gas chromatography mass spectrometry; FAB, Fast atom bombardment; HRMS, high resolution mass spectroscopy; COSYDQF, Two-dimensional (2D) phase-sensitive double quantum filtered correlation spectroscopy; TOCSY, Total correlation spectroscopy; HSQC, .